Search Results - "Hostin, Damon"
-
1
Real-world costs and outcomes associated with biomarker testing by comprehensive genomic profiling (CGP) and non-CGP approaches among patients with metastatic non-small cell lung cancer (mNSCLC)
Published in Journal of clinical oncology (01-06-2024)“…e20598 Background: Guideline-recommended molecular testing is essential for identifying appropriate targeted therapies (Rx) for treatment of mNSCLC patients…”
Get full text
Journal Article -
2
Real-world analysis of commercially insured and Medicare Advantage patients with advanced cancer and rates of molecular testing
Published in Journal of clinical oncology (01-06-2023)“…6633 Background: Guideline-recommended molecular testing has become essential for biomarker-guided clinical decision making, particularly for patients with…”
Get full text
Journal Article -
3
Abstract 14482: Low Utilization of Guideline-Recommended Genetic and Pharmacogenetic Testing Among Patients With Cardiovascular Conditions in the United States (US)
Published in Circulation (New York, N.Y.) (07-11-2023)“…Abstract only Introduction: Cardiovascular disease (CVD) continues to be the leading cause of death in the US and globally. Clinical practice guidelines…”
Get full text
Journal Article -
4
Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer
Published in JCO precision oncology (01-05-2024)“…Therapeutic decision making for patients with advanced non-small cell lung cancer (aNSCLC) includes a growing number of options for genomic, biomarker-guided,…”
Get more information
Journal Article -
5
Abstract 1319: Establishment and characterization of fresh primary human colorectal tumor implants
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract A personalized approach towards the therapy of colorectal carcinoma is critical for a successful outcome. In recent years, direct transfer xenograft…”
Get full text
Journal Article